Orphan drug costs proving ‘prohibitive’

A GP’s view: Orphan drug costs ‘prohibitive’ “Orphan drugs are designed to treat rare, life-threatening or debilitating medical conditions known as orphan diseases. In America, rare is defined as affecting less than one in 1,500 of the population, in Europe the figure is less than one in 2,000. In 1983, the US Orphan Drug Act